Table 4. Comparison of blood parameters between patients’ subgroups and healthy individuals.
| Variable | Group | M | IQR | Differences between groups | Groups with differences |
|---|---|---|---|---|---|
| WBC | FEP-nt | 6.09 | 3.22 | p = 0.008 | FEP-t>HC |
| FEP-t | 6.721 | 1.31 | |||
| HC | 5.83 | 0.99 | |||
| LYMPH | FEP-nt | 1.9 | 0.7 | p = 0.01 | FET-ut<FEP-t FET-t>HC |
| FEP-t | 2.4 | 1.09 | |||
| HC | 2.1 | 0.5 | |||
| PLR | FEP-nt | 133.55 | 67.36 | p = 0.025 | FEP-nt>-FEP-t |
| FEP-t | 96.65 | 36.55 | |||
| HC | 113.06 | 35.10 | |||
| MONO | FEP-nt | 0.56 | 0.49 | p = 0.038 | FEP-t>HC |
| FEP-t | 0.62 | 0.26 | |||
| HC | 0.51 | 0.11 | |||
| EOZ | FEP-nt | 0.18 | 0.16 | p = 0.007 | FEP-t>HC |
| FEP-t | 0.22 | 0.21 | |||
| HC | 0.11 | 0.11 | |||
| BASO | FEP-nt | 0.04 | 0.03 | p = 0.043 | FEP-t>HC |
| FEP-t | 0.04 | 0.04 | |||
| HC | 0.02 | 0.01 |
M–median, IQR—interquartile range; HC–healthy controls; FEP–first-episode psychosis; nt–untreated (drug-naive); t–treated; WBC—white blood cells; LYMPH–lymphocytes; MONO–monocytes; EOZ–eosinophils; BASO–basophils; PLR—platelets to lymphocytes ratio